chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"Feeling hot temp 97.7.  10:53 BP 173/97 HR 139 11:05 BP 134/70 HR 94 - asymptomatic Educated pt to notify manager of any additional symptoms Pt returned at 1108 w/ cc palpitations, hot, shaky and difficulty swallowing. Assessed and sent to ED. BP 159/104. In the ED, symptoms resolved and pt discharged at 13:29. "
Mild fever, dizziness, chills, malaise, body aches, severe fatigue onset  +24h, improved by +36h and resolved by +48h. Severe enough to prevent daily activity and prevented patient from caring for themselves for the duration of sx. Swelling, redness, moderate-severe pain (to the touch) at injection site.
allergy to the vaccine; High fever; Headache; Arms swollen at the injection site; This is a spontaneous report from a contactable physician reporting for self. This 42-year old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVENAR 13) via an unspecified route of administration on 05Dec2020 at single dose for immunization. The patient stated that it was a pneumococcal vaccine (unspecified PREVENAR, PREVENAR 13 or unspecified vaccine) as she did not know there was a difference. For the indication, the patient stated that because she turned 40 and she might be high risk to get it because she worked in the hospital. The patient medical history and concomitant medications were not reported. The patient experienced high fever, headache, arms swollen at the injection site. The patient mentioned an allergy to the vaccine, that caused her high fever, headache and her arms swollen at the injection site. Patient reported no treatment. Reporter assessed events high fever, arms swollen at the injection site related to the products.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
administered Pfizer purple cap vaccine; it was left in the fridge for longer then manuf. racommended. Called Pfizer and advised us to revaccinate patient.
Pt developed new onset severe reynaud's-like syndrome- fingers intermittently turning dramatically white with numbness. This is occurring without relation to environmental temperature
pt recvd vax between 4-430PM; mom returned to clinic @ 530PM w/pt crying & shaking ax temp 104; mom states had given APAP p/vax given; mom requested 911 to be called for ride to hosp; pt seen in ER for pneumonia & ear infect placed on ATB;
She let the immunizer know as she sat down in the lobby, she felt lightheaded. The pharmacist came out to check on her. She fainted and he caught her before she could hit the floor. The pharmacist and another staff member helped her to sit her upright in the chair. She finally came to. I ran to get her room temp water. She was able to call her dad to come pick her up instead of driving. We all stayed with her until she felt better, and her dad arrived.
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE; GENERALIZED WEAKNESS; ACHY; SWEATING; CHILLS; FEVER; This spontaneous report received from a patient concerned a 16 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included no alcohol use, and non-smoker, and other pre-existing medical conditions included patient had no known drug allergies or drug abuse/illicit drug usage. patient denied history of reactions to vaccines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,  batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 12:45 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced sweating. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. On 12-APR-2021 21:00, the subject experienced achy. On 12-APR-2021 21:00, the subject experienced generalized weakness. On an unspecified date, the subject experienced product administered to subject of inappropriate age, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from achy, generalized weakness, fever, chills, and sweating, and the outcome of product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Initial and follow-up information has been received from a pharmacist concerning a 64 year old female who on 09-OCT-2008 was vaccinated with a dose of ZOSTAVAX, 0.65 ML, SC into the left arm. On 10-OCT-2008, the patient developed vesicles (4 inch x 8 inch) around the injection site. It was described as a red, hot itchy rash. No blisters. The patient called her physician and was treated with Benadryl for 2 days. On 14-OCT-2008, the patient recovered. No further information is available. This is one of several reports from the same source.
Headache; pressure in head; between upper shoulders and neck - necessitating " had to sit down", nausea, no emesis, TX with TYLENOL XL (1gm) q 4 hrs daytime x 2 days.
re: Diabetes.  High blood sugar measures. 250 to 425. I have had high blood sugar numbers since my first injection, continuing to  current.
PATIENT INJECTED WITH A PRE-FILLED SYRINGE WITH A TEMP EXCURSION; PATIENTS WERE AFFECTED; This spontaneous report received from a consumer concerned a 34 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 09:05 on left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced subject injected with a pre-filled syringe with a temp excursion. On 31-MAR-2021, the subject experienced subjects were affected. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the patient injected with a pre-filled syringe with a temp excursion and patients were affected was not reported. This report was non-serious.
Information regarding Flumist was received from a healthcare professional regarding a 46 year old female pt who experienced lightheadedness, migraine headaches, blurred vision, body ache, sneezing and scratchy throat. At 46 years of age, the pt received a dose on 10/16/03. The pt's concurrent illness include migraine headaches, chronic back pain, hypothyroidism, and arthritis with a past history of sinusitis (frequent) and hysterectomy. The pt became lightheaded, and started having migraine headaches and blurred vision on 10/16/03. She then developed body aches, sneezing and a scratchy throat on 10/17/03. She recovered.
Staring spells, with mild loss of tone, ocurring multiple times starting a few minute after vax, No color changes, no jerking motions. Child irritable, with periods of lethargy. No fever exam significant only for mild irritability.
Large area of erythema with center being inject site w/a blister like area. Erythema 135 mm length and 160 mm circumference with itching at center. No fever.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 04-SEP-2015, the patient was vaccinated with an improperly stored PNEUMOVAX 23 10 PK, lot # L002310, expiration date 08-JUL-2016 at a dose of 0.5 ml, (route and anatomical location of administration were unspecified). The vaccine underwent a total temperature excursion, of 240 hours. The lowest recorded temperature was 27 Fahrenheit degrees (-2.777777778 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
10-14-10 Patient reports muscular soreness increased from date of injection from injection site to entire upper left arm by 10-14-10.
February 28, 2011: Tetanus Shot and Neurological Symptoms in Hands. Please add to file for patient: On December 1, 2010, I received a tetanus shot as part of routine physical with Dr. Within several hours, I was unable to extend my left hand without major "zings" in the fingers and up the hand. This lasted on and off for one month with "zingers" preventing me from grabbing hard at something or extending my arm straight out. Three months later the left hand is rarely having problems, and the symptoms are not as intense anymore. However, I also have the same problem to a lesser degree in my right hand now, too, which come and goes. A couple of days after the shot, I checked on the Internet to see if any symptoms were reported with tetanus shots and neurological issues. The CDC found links to a neurological condition in the shoulder, and the Immunization Action Coalition suggest avoiding DTaP shots if neurological conditions are possible (article was aimed at children's vaccines.) Several ALS patients had blogs asking if a connection existed, but their requests were speculation-based on having the shots at various time in left compared to onset of ALS. I assumed the left-hand side-effect might have been from the shot itself until the symptoms started in the other arm. While the information below is not definitive, I would like a caution added to my records regarding a tetanus shot in the future, since our family has a chance of genetic ALS. Please place this page in my records for future reference. (My father and aunt died from it at age of early 60's and late 50's, and my uncle died from Parkinson's Disease and two of his children have had long-time myasthenia gravis.)
Due to lack of pregnancy test, received shot and 2 months later had a spontaneous abortion. Was told fetus never developed past shot date.
Difficulty walking, weakness, keeping her head up, moving her left foot, and difficulty swallowing. Her ability to live alone was taken away from her.
tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ZILEUTON, start date: Feb2014; FOSAMAX, start date: Feb2018. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 22Jan2021, when the patient was 65-year-old, for Covid-19 immunization, reaction(s): "developed an escalation in the intensity of my (relatively minor) tinnitus"; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization, reaction(s): "tinnitus". The following information was reported: TINNITUS (non-serious), outcome "not recovered". Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient had received other medication in 2 weeks. She had no known allergies. Approximately three hours after receiving her first shot on 22Jan2021 she had developed an escalation in the intensity of her (relatively minor) tinnitus. Noticed no difference after the second Vax and first booster. But three hours after her second booster 08Apr2022, she experienced a very loud intensity of her tinnitus and it has not changed or subsided. This one was life altering. She does not plan to take any further covid treatments.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Headache, nausea/vomiting, fever, myalgia within 45 minutes of receiving vax. Temperature increased to 101.3. She sought medical attention and received prescription for Tigan. Compazine was administered in the office. Symptoms resolved within 48 hours.
The family states the injections were given without incidence. She had mild fever for 2 days. There was erythema at the injection sites, about the size of a nickel. MOP was concerned the left thigh site is too lateral. She continues to have hard lumps at both injection sites. She does not seem to have pain and they do not impari activity. She is otherwise baseline. She tolerated her 2 month vaccines without incidence. Physical exam showed  palpable bilateral firm, mobile, irregular, knotty, pea-sized, nontender, left slightly larger than right nodules at quadriceps injection sites with superficial skin discoloration but no signs of other local site inflammation. Family reported nodules still present on 14 AUG 2019. F/u was planned for SEPT. We telephoned on -1 OCT since they hadn't scheduled and report was sites improved and visit  was declined by family.
Drowsiness; stuffy nose; fatigue; now a month past his scheduled second dose appointment; tested positive for COVID; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (now a month past his scheduled second dose appointment), SOMNOLENCE (Drowsiness), COVID-19 (tested positive for COVID), NASAL CONGESTION (stuffy nose) and FATIGUE (fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No concomitant medications provided.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced COVID-19 (tested positive for COVID). On 27-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (now a month past his scheduled second dose appointment). On an unknown date, the patient experienced SOMNOLENCE (Drowsiness), NASAL CONGESTION (stuffy nose) and FATIGUE (fatigue). At the time of the report, PRODUCT DOSE OMISSION ISSUE (now a month past his scheduled second dose appointment) had resolved and SOMNOLENCE (Drowsiness), COVID-19 (tested positive for COVID), NASAL CONGESTION (stuffy nose) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, SARS-CoV-2 test: negative Negative. On 24-Mar-2021, SARS-CoV-2 test: positive Positive. On 09-Apr-2021, SARS-CoV-2 test: negative (Negative) On 8-9 Apr 2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported. .Patient received first dose on 26 Feb 2021 with lot (025A21A) in left upper arm(non-dominant). He was a little drowsy, fatigue and stuffy nose after first dose. He was scheduled for second dose on 26 March. On 15 March exposed to COVID, 18 March tested negative for COVID at urgent care, 24 March tested positive for COVID. He quarantined. He tested negative for COVID around 8-9 April. Patient is now a month past his scheduled second dose appointment.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Added Patient's phone number.
electrical jolt in her jaw; numbness in her lips; tightening in neck area; tingling in lips; slight chills; Her nerves felt on fire / neck and jaw felt like it was on fire; slight ache in her jaw and teeth; This is a spontaneous report received from Pfizer medical information team from a contactable consumer or other non hcp (patient).  A 69-years-old female patient received BNT162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Lot No, NDC number, Expiry date: was not reported), via an unspecified route of administration on Feb2021 as 2nddose, single for covid-19 immunisation. Historical vaccine was a 69-years-old female patient received BNT162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Lot No: was not reported), via an unspecified route of administration on unspecified date as 1stdose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced electrical jolt in her jaw, numbness in her lips, tightening in neck area, tingling in lips, slight chills, her nerves felt on fire / neck and jaw felt like it was on fire, slight ache in her jaw and teeth in 2021. Patient was planning to get her 3rd dose. Upon follow-up on 23Sep2021new information was updated. This is a follow-up spontaneous report received a contactable consumer (patient) that reported about adverse event, dates for COVID vaccine (Start: Unspecified Stop: Unspecified), reason for no lot number of COVID vaccine patient was unwilling to complete the report. Other products not provided; patient history was not provided. Investigation assessment was not provided. There is no information out there for the general public about side effects. She is turning 70. It felt like she had received Novocain at the dentist, and it was wearing off, and there was tingling in her lips. She had a very slight lip tingle on and off for a couple of days. The clinical outcome of the events was recovered.  Follow-up (23Sep2021). This is a follow-up spontaneous report received a contactable consumer (patient) that reported about adverse event, dates for COVID vaccine (Start: Unspecified Stop: Unspecified), reason for no lot number of COVID vaccine patient was unwilling to complete the report. Other products were not provided, patient history was not provided. Investigation assessment was not provided. There is no information out there for the general public about side effects. She is turning 70. It felt like she had received Novocain at the dentist, and it was wearing off, and there was tingling in her lips. She had a very slight lip tingle on and off for a couple of days.  Follow-up attempts are completed. No further information is expected.
Patient received vaccine on 4/2/2021, then started having pain on her left clavicle/neck area about a week after. She presented to ED on 4/15/2021, had diagnostic study done which showed acute DVT.
Patient was diagnosed with intussusception via abdominal ultrasound; she presented with billous vomiting for 2 days and was then admitted to Medical Center, where she was diagnosed by myself. While in the hospital she had a barium enema reduction of the intussusception that reduced the ailment without surgery. Patient was discharged the next day in stable condition. She was found to have the Rotavirus vaccine (as well as her other 2 month vaccines) given on 02/05/2014 by her PMD.
Information has been received from a nurse referring to a few patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored GARDASIL (lot # K006960, expiration date 19-FEB-2017, dose and route were unknown). No adverse effects were reported. This is one of two reports from the same reporter. Additional information is not expected because the reporter does not want to be contacted further.
DIZZINESS,  HEADACHE AND TOTAL EXHAUSTION FOR 2 DAYS.
Pt received vax /w Engerix B , next day had onset of back pain, lt side, lymph nodes lt neck tender/enlarged, pulled muscle.
Low grade fever; chills; Body aches; headache; This is a spontaneous report from a non-contactable consumer. This 28-year-old non-pregnant female patient received bnt162b2 (PFIZER COVID-19 Vaccine, Solution for injection, lot number: EL3248), via an unspecified route of administration on 12Feb2021 07:00 AM (at the age of 28-year-old) at dose 2, single at left arm for COVID-19 immunisation. The medical history included Migraines and Bacterium allergy. Concomitant medications were not reported. The patient had not received any other vaccine in four weeks of vaccination. The patient did not have covid prior vaccination. The patient was not tested positive for covid post vaccination. The historic vaccine included bnt162b2 (PFIZER COVID-19 Vaccine, Lot number: EL3248) on 22Jan2021 at 03:00 PM on right arm as dose 1, single for COVID-19 immunisation. On 13Feb2021, the patient experienced low grade fever, chills, body aches, headache. The patient did not receive any treatment for the events. Outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Fatigue, fever, joint pain, muscle weakness, swelling in legs, knees, and feet, numbness and tingling in toes, arms with hands frequently have loss of sensation, presently unable to bend knees, muscle stiffness and soreness in back and chest area (feel like it's internal), total body muscle stiffness and pain.
On 03/24/2021, which was one week after my 2nd covid pfizer vaccination, I started to experience ringing in both ears, which has continued nonstop ever since. After doing considerable reading about this, ringing in the ears has been an all to common side effect of the covid vaccines. I have discovered that it is called tinnitis. Regardless of it's name, phizer & the other covid vaccine makers need to solve this major problem for those of us who have it because of their covid vaccines. I have never had ringing in the ears ever before. I have always been in perfect health and have not taken prescription drugs.  I should have had only ONE covid vaccine shot
1 1/2 hours after injection-violent evacuation of bowels. Pain at site almost immediate. Bone pain to all extremities starting in legs then arms. Weakness and fatigue followed by chills-remained in bed for 20 hours. Site and extremity pain continues but improving somewhat.
12 hours after shot, red swollen eyes, fatigue, body ache, tenderness and swelling of left arm. Shortly after chills, fever, swelling of lymph nodes, migraine, rapid heart rate, dizzy, nausea.  Lasted about 36 hours. migraine, fatigue, body aches, selling of lymph nodes still present after 48 hours.  72 hours later bruised lymph nodes through out the body (left leg, right upper arm, and right rib cage.) Also noticeable joint and muscle pain. prominently lower back, and right rib cage.
On 08/11/21 patient came to the pharmacy with his 3 other family members (total of 4 people) for COVID vaccine. Rph administered Pfizer Covid Vaccine (dose 1) to the patient in a stand-up position and soon after patient fainted on the ground. He re-gained his conciousness right away. Rph called the store director. Rph asked patient to be sitting down on the ground and measured his bloodpressure - it was read 107/68. When Rph asked patient what his normal BP was, patient or the family members did not know. No history of hypertension was listed on the consent form. Rph monitored patient for 30 minutes and instructed him to seek medical care if necessary.
Ache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache) and FATIGUE (Tiredness) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ache) and FATIGUE (Tiredness). The patient was treated with ADALIMUMAB (HUMIRA) (subcutaneous) for Rheumatoid arthritis, at an unspecified dose and frequency. At the time of the report, PAIN (Ache) and FATIGUE (Tiredness) outcome was unknown.            Labs data included were: Pain Scale Test - Results not provided.  Concomitant product use was not provided by the reporter.    Reporter did not allow further contact
pt c/o chills, fever, nausea & generalized weakness w/in 30 hrs of receiving Hep B vax; also devel sore throat; sx are transient; cont to feel fatigued & nauseated; seen by MD;